Xiaoyang WANG

Ms. Xiaoyang WANG

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
SLShengying LIN
Shengying LIN
XWXiaoyang WANG
Xiaoyang WANG
RTRoy Wai-Lun Tang Roy Wai-Lun Tang
Roy Wai-Lun Tang Roy Wai-Lun Tang
HLHung Chun Lee
Hung Chun Lee
HCHo Hin Chan
Ho Hin Chan
Karl TsimKarl Tsim
Karl Tsim
COVID-19, resulting from infection by the SARS-CoV-2 virus, caused a contagious pandemic. Even with the current vaccines, there is still an urgent need to develop effective pharmacological treatments against this deadly disease. Here, we show that the water and ethanol extracts of the root and rhizome of Polygonum cuspidatum (Polygoni Cuspidati Rhizoma et Radix), a common Chinese herbal medicine, blocked the entry of wild-type and the omicron variant of the SARS-CoV-2 pseudotyped virus into fibroblasts or zebrafish larvae, with IC50 values ranging from 0.015 to 0.04 mg/mL. The extracts were shown to inhibit various aspects of the pseudovirus entry, including the interaction between the spike protein (S-protein) and the angiotensin-converting enzyme II (ACE2) receptor, and the 3CL protease activity. Out of the chemical compounds tested in this report, gallic acid, a phytochemical in P. cuspidatum, was shown to have a significant anti-viral effect. Therefore, this might be responsible, at least in part, for the anti-viral efficacy of the herbal extract. Together, our data suggest that the extracts of P. cuspidatum inhibit the entry of wild-type and the omicron variant of SARS-CoV-2, and so they could be considered as potent treatments against COVID-19.

Verified
Journal Article
Open access
PDF file
SLShengying LIN
Shengying LIN
XWXiaoyang WANG
Xiaoyang WANG
HGHongsheng Guo
Hongsheng Guo
NDNiyu Dai
Niyu Dai
RTRoy Wai-Lun Tang Roy Wai-Lun Tang
Roy Wai-Lun Tang Roy Wai-Lun Tang
Karl TsimKarl Tsim
Karl Tsim
COVID-19, derived from SARS-CoV-2, has resulted in millions of deaths and caused unprecedented socioeconomic damage since its outbreak in 2019. Although the vaccines developed against SARS-CoV-2 provide some protection, they have unexpected side effects in some people. Furthermore, new viral mutations reduce the effectiveness of the current vaccines. Thus, there is still an urgent need to develop potent non-vaccine therapeutics against this infectious disease. We recently established a series of detecting platforms to screen a large library of Chinese medicinal herbs and phytochemicals. Here, we reveal that the ethanolic extract of Evodiae Fructus and one of its components, rutaecarpine, showed promising potency in inhibiting the activity of 3C-like (3CL) protease, blocking the entry of the pseudo-typed SARS-CoV-2 (including wild-type and omicron) into cultured cells. In addition, inflammatory responses induced by pseudo-typed SARS-CoV-2 were markedly reduced by Evodiae Fructus extract and rutaecarpine. Together our data indicate that the herbal extract of Evodiae Fructus and rutaecarpine are potent anti-SARS-CoV-2 agents, which might be considered as a treatment against COVID-19 in clinical applications.

23 August 2013 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
FZFanglong Zhao
Fanglong Zhao
CXChaoyou Xue
Chaoyou Xue
MWMeiling Wang
Meiling Wang
XWXiaoyang WANG
Xiaoyang WANG
WLWenyu Lu
Wenyu Lu
Metabolomics analysis of three Saccharopolyspora spinosa strains (wild type strain WT, ultraviolet mutant strain WH124, and metabolic engineering strain LU104) with different spinosad producing levels was performed by liquid chromatograph coupled to mass spectrometry (LC-MS). The metabolite profiles were subjected to hierarchal clustering analysis (HCA) and principal component analysis (PCA). The results of HCA on a heat map revealed that the large numbers of primary metabolism detected were more abundant in WH124 and less abundant in LU104 during the early fermentation stage as compared to the WT strain. PCA separated the three strains clearly and suggested nine metabolites that contributed predominantly to the separation. These biomarkers were associated with central carbon metabolism (succinic acid, α-ketoglutarate, acetyl-CoA, and ATP), amino acid metabolism (glutamate, glutamine, and valine), and secondary metabolism (pseudoaglycone), etc. These findings provide insight into the metabolomic characteristics of the two high-yield strains and for further regulation of spinosad production.


21 December 2022 in Journal of Virology
Verified
Journal Article
Closed access
SCSheyne S. A. Choi
Sheyne S. A. Choi
HCHo Hin Chan
Ho Hin Chan
CCChing Man Chan
Ching Man Chan
XWXiaoyang WANG
Xiaoyang WANG
SWSarah E. Webb
Sarah E. Webb
AMAndrew L. Miller
Andrew L. Miller
Despite the development of effective vaccines to combat the COVID-19 pandemic, which help prevent the most life-threatening symptoms, full protection cannot be guaranteed, especially with the emergence of new viral variants. Moreover, some resistance to vaccination remains in certain age groups and cultures.

3 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
SLShengying LIN
Shengying LIN
XWXiaoyang WANG
Xiaoyang WANG
RTRoy Wai-Lun Tang Roy Wai-Lun Tang
Roy Wai-Lun Tang Roy Wai-Lun Tang
RDRan Duan
Ran Duan
WLWing LEUNG
Wing LEUNG
Karl TsimKarl Tsim
Karl Tsim
COVID-19 continues to spread around the world. This is mainly because new variants of the SARS-CoV-2 virus emerge due to genomic mutations, evade the immune system and result in the effectiveness of current therapeutics being reduced. We previously established a series of detection platforms, comprising computational docking analysis, S-protein-based ELISA, pseudovirus entry, and 3CL protease activity assays, which allow us to screen a large library of phytochemicals from natural products and to determine their potential in blocking the entry of SARS-CoV-2. In this new screen, rutaecarpine (an alkaloid from Evodia rutaecarpa) was identified as exhibiting anti-SARS-CoV-2 activity. Therefore, we conducted multiple rounds of structure-activity-relationship (SAR) studies around this phytochemical and generated several rutaecarpine analogs that were subjected to in vitro evaluations. Among these derivatives, RU-75 and RU-184 displayed remarkable inhibitory activity when tested in the 3CL protease assay, S-protein-based ELISA, and pseudovirus entry assay (for both wild-type and omicron variants), and they attenuated the inflammatory response induced by SARS-CoV-2. Interestingly, RU-75 and RU-184 both appeared to be more potent than rutaecarpine itself, and this suggests that they might be considered as lead candidates for future pharmacological elaboration.